ADVISORY AGREEMENTAdvisory Agreement • November 10th, 2015 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2015 Company Industry JurisdictionThis ADVISORY AGREEMENT (this “Agreement”), is entered into effective as of October 28, 2015, by and between Lixte Biotechnology Holdings, Inc., a Delaware corporation (the “Company”), and Fritz Henn, M.D., Ph.D. (“Advisor”).
STOCK OPTION AGREEMENTStock Option Agreement • November 10th, 2015 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 10th, 2015 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (“Agreement”) is made as of October 28, 2015 (the “Grant Date”) by and between LIXTE BIOTECHNOLOGY HOLDINGS, INC., a Delaware corporation (the “Company”), and FRITZ HENN, M.D., Ph.D. (the “Optionee”).